The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
Stefan Hof, Clinical scientist and anesthesiologist at University Hospital of Düsseldorf, shared on LinkedIn:
”Together with our medical doctoral candidate Annalena Müllers we enrolled the first participant in our new clinical study – the CHECK-NIRS study.
In this project, we will systematically investigate external and behavioural factors influencing NIRS-based 2D-imaging.
This marks an important first step in translating our predominantly experimental findings into clinical application, with the goal of gaining deeper insights into tissue oxygenation in humans.
I am particularly looking forward to collaborating with Patricia Wischmann from the Department of Cardiology, Pneumology and Angiology at University Hospital Düsseldorf, Kalman Bodis from the Department of Endocrinology and Diabetology at University Hospital Düsseldorf and Katharina Post from inovex GmbH.
A big thank you to everyone involved for your dedication and teamwork!”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 07:28Isabelle Grenier-Pleau: Targeting Von Willebrand Disease to Transform Women’s Health
-
Sep 23, 2026, 07:07Wolfgang Miesbach: Mechanisms of Liver Injury After Hemophilia A Gene Therapy
-
Sep 23, 2026, 06:24Nicolas Gendron: Everolimus and Venous Thromboembolic Risk in Kidney Transplantation
-
Sep 23, 2026, 06:07Hoori Shahwar: Cerebral Venous Sinus Thrombosis Diagnosis and Management
-
Sep 23, 2026, 06:06Advancing Hemophilia Care and Patient Advocacy in Bangladesh – World Federation of Hemophilia
-
Sep 23, 2026, 05:54Bringing the Global Thrombosis and Haemostasis Community Together in 2027 – ISTH
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:13Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets